-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PGWUqb9gyiNVOXgkrE06m3cE8eLQsciGbZft60rOfy53ZCJYzzRH6qVDVKHn3v21 oE3zkurlZjTuYPoF4f0hYw== 0001209191-09-051305.txt : 20091105 0001209191-09-051305.hdr.sgml : 20091105 20091105190650 ACCESSION NUMBER: 0001209191-09-051305 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091103 FILED AS OF DATE: 20091105 DATE AS OF CHANGE: 20091105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scalet J Chris CENTRAL INDEX KEY: 0001348912 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 091162437 MAIL ADDRESS: STREET 1: MERCK & CO., INC. STREET 2: ONE MERCK DRIVE, PO BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 FORMER NAME: FORMER CONFORMED NAME: Scalet James Christopher DATE OF NAME CHANGE: 20060105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co. Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DRIVE STREET 2: P.O. BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 908 423 1688 MAIL ADDRESS: STREET 1: ONE MERCK DRIVE STREET 2: P.O. BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 c92126_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4 2009-11-03 0000310158 Merck & Co. Inc. MRK 0001348912 Scalet J Chris ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889-0100 0 1 0 0 Exe. VP, Global Services & CIO Common Stock 2009-11-03 4 A 0 26167.8585 0.0000 A 0.0000 D Common Stock - 401(k) Plan 2009-11-03 4 J 0 2608.7358 0.0000 A 0.0000 I By 401(k) Restricted Stock Unit 2009-11-03 4 A 0 7650.0000 0 A 2010-03-02 2010-03-02 Common Stock 7650.0000 0.0000 D Restricted Stock Unit 2009-11-03 4 A 0 9750.0000 0 A 2011-02-28 2011-02-28 Common Stock 9750.0000 0.0000 D Restricted Stock Unit 2009-11-03 4 A 0 11700.0000 0 A 2012-04-24 2012-04-24 Common Stock 11700.0000 0.0000 D RSU - Leader Shares 2009-11-03 4 A 0 15000.0000 0 A 2012-04-24 2012-04-24 Common Stock 15000.0000 0.0000 D Stock Option (right to buy) 52.2849 2009-11-03 4 A 0 31650.0000 0 A 2004-03-25 2013-03-24 Common Stock 31650.0000 0.0000 D Stock Option (right to buy) 54.9958 2009-11-03 4 A 0 42200.0000 0 A 2004-05-01 2013-04-30 Common Stock 42200.0000 0.0000 D Stock Option (right to buy) 48.2400 2009-11-03 4 A 0 21750.0000 0 A 2005-02-27 2014-02-26 Common Stock 21750.0000 0.0000 D Stock Option (right to buy) 31.8400 2009-11-03 4 A 0 25000.0000 0 A 2006-02-25 2015-02-24 Common Stock 25000.0000 0.0000 D Stock Option (right to buy) 35.0900 2009-11-03 4 A 0 36000.0000 0 A 2007-03-03 2016-03-02 Common Stock 36000.0000 0.0000 D Stock Option (right to buy) 44.1900 2009-11-03 4 A 0 40800.0000 0 A 2008-03-02 2017-03-01 Common Stock 40800.0000 0.0000 D Stock Option (right to buy) 44.3000 2009-11-03 4 A 0 52000.0000 0 A 2009-02-28 2018-02-28 Common Stock 52000.0000 0.0000 D Stock Option (right to buy) 23.4500 2009-11-03 4 A 0 62400.0000 0 A 2010-04-24 2019-04-23 Common Stock 62400.0000 0.0000 D Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Received as part of the Transactions in exchange for an equivalent number of shares of MSD common stock held under the MSD 401(k) plan. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Debra A. Bollwage as Attorney-in-Fact for J. Chris Scalet 2009-11-05 -----END PRIVACY-ENHANCED MESSAGE-----